✅ #FIDELITY Analysis: finerenone reduces the risk of #CV and renal outcomes compared to placebo in patients with type 2 #diabetes and all stages of kidney disease

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫